Author | Martin Forster, MD | OncLive

Author | Martin Forster, MD

Articles

Dr. Forster on Next Steps With Lurbinectedin in SCLC

October 11, 2018

Video

Martin Forster, MD, a medical oncologist, University College London Hospitals, discusses the next steps with the investigational agent lurbinectedin in combination with doxorubicin as a second-line therapy for patients with small cell lung cancer (SCLC).

Dr. Forster on Recent Data With Lurbinectedin in SCLC

October 08, 2018

Video

Martin Forster, MD, a medical oncologist, University College London Hospitals, discusses data of lurbinectedin plus doxorubicin as a second-line therapy for patients with small cell lung cancer.

Dr. Forster Discusses the ATLANTIS Study in Small-Cell Lung Cancer

October 05, 2017

Video

Martin Forster, MD, medical oncologist, University College London Hospitals, discusses the ATLANTIS study in small-cell lung cancer.

x